Related Experiment Video
Updated: Apr 16, 2026
04:23
Application of Hemostatic Devices in Laparoscopic Hepatectomy
Published on: April 19, 2022
3.0K
[Hepatocellular adenoma - new classification and recommendations].
Luise Aamann, Nicolai Schultz, Eva Fallentin
1Medicinsk Hepato-gastroenterologisk -Afdeling V, Aarhus Universitetshospital, Nørrebrogade 44, 8000 Aarhus C. henngroe@rm.dk.
Ugeskrift for Laeger
|March 20, 2015
Summary
Hepatocellular adenoma (HCA), a benign liver tumor, can bleed or become cancerous (HCC). New molecular data informs a revised classification and updated treatment guidelines for HCAs.
Area of Science:
- Hepatology
- Oncology
- Genetics
Background:
- Hepatocellular adenoma (HCA) is a rare benign liver tumor.
- Complications include bleeding and malignant transformation to hepatocellular carcinoma (HCC).
- Risk factors for HCC include male gender, large size (>8cm), and specific subtypes.
Purpose of the Study:
- To review and update the classification of HCAs based on molecular genetic analyses.
- To provide current recommendations for the diagnosis and treatment of HCAs.
Main Methods:
- Review of recent molecular genetic analyses of HCAs.
- Integration of genotypic and phenotypic data for classification.
Main Results:
- A new classification system for HCAs based on molecular and clinical features.
- Identification of key risk factors for malignant transformation.
Conclusions:
- The new classification refines understanding of HCA subtypes.
- Updated diagnostic and therapeutic strategies are proposed for improved patient management.
